Midazolam Nasal Spray to Treat Intermittent, Stereotypic Episodes of Frequent Seizure Activity: Pharmacology and Clinical Role, a Comprehensive Review

Overview

Journal Health Psychol Res

Date 2022 Oct 20

PMID 36262479

Authors

Elyse M Cornett

Meskerem A Nemomsa

Bailey Turbeville

Matthew A Busby

Jessica S Kaye

Aaron J Kaye

JooHee Choi

Giovanni F Ramirez

Giustino Varrassi

Adam M Kaye

Alan D Kaye

James Wilson

Latha Ganti

Affiliations

Soon will be listed here.

Abstract

An intranasal formulation of midazolam, Nayzilam, has been FDA-approved to treat intermittent, stereotypic episodes of frequent seizure activity. Nayzilam is easy to administer and can quickly treat seizures that occur outside of the hospital. The intra-nasal route of administration allows non-medical personal to administer the drug which makes it more accessible and user-friendly in the event of a seizure. Many studies have indicated quick cessation of seizures with Nayzilam compared to rectal diazepam, which has been the standard of care treatment. Nayzilam has been proven to be safe and effective for acute seizures in children, deeming it a revolutionary alternative in times where intravenous administration is not possible.

Citing Articles

Development of , an Epinephrine Nasal Spray, for Severe Allergic Reactions.

Ellis A, Casale T, Kaliner M, Oppenheimer J, Spergel J, Fleischer D Pharmaceutics. 2024; 16(6).

PMID: 38931932 PMC: 11207568. DOI: 10.3390/pharmaceutics16060811.

Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery.

Maher R, Moreno-Borrallo A, Jindal D, Mai B, Ruiz-Hernandez E, Harkin A Pharmaceutics. 2023; 15(3).

PMID: 36986607 PMC: 10051709. DOI: 10.3390/pharmaceutics15030746.

References

von Blomberg A, Kay L, Knake S, Fuest S, Zollner J, Reif P . Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring. CNS Drugs. 2020; 34(5):545-553. PMC: 7198639. DOI: 10.1007/s40263-020-00720-w. View

Javadzadeh M, Sheibani K, Hashemieh M, Saneifard H . Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial. Iran J Pediatr. 2012; 22(1):1-8. PMC: 3448208. View

Bergman I, Steeves M, Burckart G, Thompson A . Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr. 1991; 119(4):644-9. DOI: 10.1016/s0022-3476(05)82420-5. View

Kalviainen R . Intranasal therapies for acute seizures. Epilepsy Behav. 2015; 49:303-6. DOI: 10.1016/j.yebeh.2015.04.027. View

Holsti M, Sill B, Firth S, Filloux F, Joyce S, Furnival R . Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care. 2007; 23(3):148-53. DOI: 10.1097/PEC.0b013e3180328c92. View

Allali J, Saule C, Chauve C, dAubenton-Carafa Y, Denise A, Drevet C . BRASERO: A Resource for Benchmarking RNA Secondary Structure Comparison Algorithms. Adv Bioinformatics. 2012; 2012:893048. PMC: 3366197. DOI: 10.1155/2012/893048. View

Bachhuber M, Hennessy S, Cunningham C, Starrels J . Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013. Am J Public Health. 2016; 106(4):686-8. PMC: 4816010. DOI: 10.2105/AJPH.2016.303061. View

Kalivas P . The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009; 10(8):561-72. DOI: 10.1038/nrn2515. View

Foti R, Rock D, Wienkers L, Wahlstrom J . Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation. Drug Metab Dispos. 2010; 38(6):981-7. DOI: 10.1124/dmd.110.032094. View

10.

Votaw V, Geyer R, Rieselbach M, McHugh R . The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 2019; 200:95-114. PMC: 6639084. DOI: 10.1016/j.drugalcdep.2019.02.033. View

11.

Owusu K, Dhakar M, Bautista C, McKimmy D, Cotugno S, Sukumar N . Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit. Epilepsy Behav. 2019; 98(Pt A):161-167. DOI: 10.1016/j.yebeh.2019.07.021. View

12.

Zhu S, Noviello C, Teng J, Walsh Jr R, Kim J, Hibbs R . Structure of a human synaptic GABA receptor. Nature. 2018; 559(7712):67-72. PMC: 6220708. DOI: 10.1038/s41586-018-0255-3. View

13.

Best K, Boullata J, Curley M . Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model. Pediatr Crit Care Med. 2015; 16(2):175-83. PMC: 5304939. DOI: 10.1097/PCC.0000000000000306. View

14.

Fisgin T, Gurer Y, Tezic T, Senbil N, Zorlu P, Okuyaz C . Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol. 2002; 17(2):123-6. DOI: 10.1177/088307380201700206. View

15.

Brett J, Murnion B . Management of benzodiazepine misuse and dependence. Aust Prescr. 2015; 38(5):152-5. PMC: 4657308. DOI: 10.18773/austprescr.2015.055. View

16.

Kanto J . Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy. 1985; 5(3):138-55. DOI: 10.1002/j.1875-9114.1985.tb03411.x. View

17.

Detyniecki K, Van Ess P, Sequeira D, Wheless J, Meng T, Pullman W . Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial. Epilepsia. 2019; 60(9):1797-1808. PMC: 9291143. DOI: 10.1111/epi.15159. View

18.

Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C . Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010; 164(8):747-53. DOI: 10.1001/archpediatrics.2010.130. View

19.

Madden J, Chappel J, Zuspan F, Gumpel J, Mejia A, Davis R . Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977; 127(2):199-201. DOI: 10.1016/s0002-9378(16)33250-1. View

20.

Humphries L, Eiland L . Treatment of acute seizures: is intranasal midazolam a viable option?. J Pediatr Pharmacol Ther. 2013; 18(2):79-87. PMC: 3668946. DOI: 10.5863/1551-6776-18.2.79. View